New risk model is able to identify patients with a low risk of progression in systemic sclerosis

by Jeska De Vries-Bouwstra, Tom Huizinga, Cornelia Allaart, Jacopo Ciaffi, Robbert Goekoop, Nina Marijn van Leeuwen, Marc Maurits, Sophie Liem, Maarten Ninaber, Henrike Gillet van Dongen
Published 2021-08-01

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis

by Miki Takata, Elena Pachera, Mojca Frank-Bertoncelj, Anastasiia Kozlova, Astrid Jüngel, Michael L. Whitfield, Shervin Assassi, Maurizio Calcagni, Jeska de Vries-Bouwstra, Tom W. Huizinga, Fina Kurreeman, Gabriela Kania, Oliver Distler
Published 2019-05-01

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

by Elena López-Isac, Marialbert Acosta-Herrera, Martin Kerick, Shervin Assassi, Ansuman T. Satpathy, Jeffrey Granja, Maxwell R. Mumbach, Lorenzo Beretta, Carmen P. Simeón, Patricia Carreira, Norberto Ortego-Centeno, Ivan Castellvi, Lara Bossini-Castillo, F. David Carmona, Gisela Orozco, Nicolas Hunzelmann, Jörg H. W. Distler, Andre Franke, Claudio Lunardi, Gianluca Moroncini, Armando Gabrielli, Jeska de Vries-Bouwstra, Cisca Wijmenga, Bobby P. C. Koeleman, Annika Nordin, Leonid Padyukov, Anna-Maria Hoffmann-Vold, Benedicte Lie, European Scleroderma Group†, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Australian Scleroderma Interest Group (ASIG), Timothy Vyse, Ariane L. Herrick, Jane Worthington, Christopher P. Denton, Yannick Allanore, Matthew A. Brown, Timothy R. D. J. Radstake, Carmen Fonseca, Howard Y. Chang, Maureen D. Mayes, Javier Martin
Published 2019-10-01